Contacts, documents and full notice history are available with a subscription.
Combined Synopsis/Solicitation NONE Expired 2 notices 6 documents

Vaccines for Children (VFC) FY26 000HCJBC-2025-95504

Solicitation 000HCJBC-2025-95504 Copied Notice ID 5d66384610f64777ae0f5e3aa315ec30 Copied HEALTH AND HUMAN SERVICES, DEPARTMENT OF — CDC OFFICE OF ACQUISITION SERVICES
SAM.gov
Posted
Dec 19, 2025
Deadline
Jan 14, 2026
Set-aside
NONE
NAICS
325412
PSC
6505

Summary

AI-generated · Dec 18, 2025

Contracts with manufacturers are sought to supply standard commercial pediatric vaccines under the Vaccines for Children (VFC) program. These contracts enable federal and state purchase and distribution of vaccines to cover a defined group of children and help ensure effective immunization practices and higher coverage. Awarded contracts may allow additional vaccine purchases at prices below the commercial market, funded through VFC and Section 317 vaccine purchase funds.

Eligible children include Medicaid-eligible, uninsured, American Indian/Alaska Native, or insured children whose vaccines aren’t covered by their plan when immunizations are provided at Federally-qualified health centers or rural health clinics. Providers meeting program requirements can receive free vaccine through VFC via state administration. Bidders must be manufacturers of pediatric vaccines, defined as entities that manufacture, import, process, or distribute vaccines under their own label.

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.

From Combined Synopsis/Solicitation posted on Dec 17, 2025

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines. Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of 1993 (OBRA '93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children. The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage. Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are(1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA '93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act). Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program. The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace. In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42 U.S.C. (S)1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.

From Combined Synopsis/Solicitation posted on Dec 19, 2025

Notice history

2
  1. Combined Synopsis/Solicitation Posted Dec 17, 2025 View
  2. Combined Synopsis/Solicitation LATEST Posted Dec 19, 2025
    • Response Deadline: Jan 07, 2026Jan 14, 2026

Details

Solicitation number 000HCJBC-2025-95504
Notice ID 5d66384610f64777ae0f5e3aa315ec30
Notice type Combined Synopsis/Solicitation
Product / Service (PSC) 6505
NAICS 325412
Set-aside No Set aside used
Place of performance Atlanta, Georgia
Archive date Jan 29, 2026

Award Information

Not yet awarded

Contacts

primary
James Sprigler

Email

secondary
Chad Turner

Email

Agency

HEALTH AND HUMAN SERVICES, DEPARTMENT OF
CENTERS FOR DISEASE CONTROL AND PREVENTION
CDC OFFICE OF ACQUISITION SERVICES

Place of Performance

Atlanta, Georgia 30341
USA

Dates

Posted Dec 19, 2025 7 months ago
Last Updated Aug 06, 2026 2 days ago
Due Jan 14, 2026 6 months ago